Economy
Tender Results of Government Treasury Bills Worth RO 20 Million Issued
Muscat: A tender of Government Treasury Bills, issue number 123, worth RO 20 Million was announced this week.
The Treasury Bills are short-term highly secured financial instruments issued by the Ministry of Finance, and they provide licensed commercial banks the opportunity to invest their surplus funds. The Central Bank of Oman (CBO) acts as the Issue Manager and provides the added advantage of ready liquidity through discounting and repurchase facilities (Repo).
The results of the said issue are as follows: The total value of the allotted Treasury bills amounted to RO 20 million, for a maturity period of 28 days, from 18 August 2021 until 15 September 2021. The average accepted price reached 99.950 for every RO 100, and the minimum accepted price arrived at 99.950 per RO 100.
The average discount rate and the average yield reached 0.65179% and 0.65211%, respectively.
The interest rate on the Repo operations with CBO is 0.5% while the discount rate on the Treasury Bills Discounting Facility with CBO is 0.75%.
Furthermore, Treasury Bills promote the local money market by creating a benchmark yield curve for short-term interest rates. Additionally, the Government may also resort to this instrument whenever felt necessary for financing its recurrent expenditures.
-
Banking & Finance2 months agoBank Muscat posts net profit of RO137.49 million in H1 2026
-
Magazines2 weeks agoOER Magazine July Edition 2026
-
Highlights3 weeks agoOERLive: Top 10 Mathematical Problems AI Has Solved or Transformed
-
Banking & Finance1 month agoOman Housing Bank launches digital waiting list for housing loans
-
Magazines2 weeks agoAl Mar’a Magazine July 2026
-
News4 weeks agoMade by Google 2026: Top 10 Biggest Launches You Need to Know – From the New Pixel 11 to a Life-Saving AI Watch
-
Alamaliktistaad Magazines2 weeks agoAlam Al-Iktisaad Magazine July 2026 Edition
-
Banking & Finance4 weeks agoOman Arab Bank CEO Sulaiman Al Harthi Retires as Ali Al Mani Is Named Successor
